WallStSmart
OGEN

Oragenics Inc

NYSE MKT: OGEN · HEALTHCARE · BIOTECHNOLOGY

$0.60
-1.21% today

Updated 2026-04-29

Market cap
$2.62M
P/E ratio
P/S ratio
89.28x
EPS (TTM)
$-4.56
Dividend yield
52W range
$1 – $10
Volume
0.3M

Oragenics Inc (OGEN) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-2.22M$-1.91M$-3.84M$-5.80M$-6.45M$-5.49M$-5.21M$-6.76M$-5.56M$-5.10M$-7.08M$-6.36M$-9.08M$-13.01M$-16.95M$-13.47M$-15.23M$-7.29M$-8.60M$-9.25B
Capital expenditures$12011.00$12906.00$55322.00$9073.00$88084.00$0.00$11095.00$18809.00$110673.00$102511.00$27179.00$124727.00$124727.00$25214.00$43876.00$43876.00$127519.00$1.00M$0.00$3.00
Depreciation
Stock-based comp$996120.00$161471.00$513611.00$392129.00$667222.00$1.26M$1.28M$3.45M$287032.00$1.03M$638418.00$560478.00$1.02M$552997.00$1.49M$1.69M$742203.00$1.02M$516049.00$642.36M
Free cash flow$-2.24M$-1.93M$-3.89M$-5.81M$-6.54M$-5.49M$-5.22M$-6.78M$-5.67M$-5.21M$-7.10M$-6.49M$-9.20M$-13.04M$-17.00M$-13.51M$-15.36M$-8.29M$-8.60M$-9.25B
Investing cash flow
Financing cash flow
Dividends paid$210.70M$0.00$0.00$0.00$0.00$0.00$0.00$58670.00$413214.00$661458.00$1.12M$1.12M
Share repurchases
Debt repayment
Net change in cash$39636.00$9.75M$6.35M$-5.83M$-5.37M$-948582.00$2.09M$14.04M$-1.94M$-628419.00